Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/2001
08/16/2001EP1007006A4 Cefadroxil monohydrate tablet formulation
08/16/2001EP0939670B1 Novel compositions with alkylglycosides and fatty alcohols base
08/16/2001EP0939635B1 Improved intraocular irrigating solution containing a polyamine antagonist
08/16/2001EP0812199A4 Sphingosine, methylsphingosine and apoptosis
08/16/2001EP0771189B1 Inhalation composition
08/16/2001EP0768876B1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
08/16/2001EP0760654B1 Process for producing active agent preparations in the form of a solid solution of the active agent in a polymer matrix
08/16/2001EP0748626B1 Patch containing isosorbide dinitrate and prepared by using adhesive mixture
08/16/2001EP0725634B1 Plaster for the treatment of nail mycoses
08/16/2001EP0706380B1 Encapsulated medicine
08/16/2001EP0702958B1 Vaginal preparation containing physiologically active peptide
08/16/2001EP0587639B1 Pharmaceutical compositions
08/16/2001EP0552256B1 Method of treating or preventing type 1 diabetes by oral administration of insulin
08/16/2001DE19941221A1 Zugabe von wasserlöslichen (hydrophilen) Vitaminen und/oder Mineralstoffen und/oder Spurenelementen zu einer üblichen kaubaren Masse (Kaugummi) Adding water-soluble (hydrophilic) vitamins and / or minerals and / or trace elements to a common chewable mass (chewing gum)
08/16/2001DE10006044A1 System, useful for administering hormone for blood glucose regulation of patient, comprises regulation unit with controller for processing measured data, and device for administering hormone
08/16/2001DE10005957A1 Verfahren zum Einbringen von Wirkstoffträgern in den intraokularen Raum und Wirkstoffträger Method for introducing drug makers in the intraocular space and drug carriers
08/16/2001DE10005942A1 Production of graft copolymers used e.g. as coatings by polymerizing vinyl esters in presence of solid polyether comprises using liquid polyalkylene glycol as solvent for radical initiator
08/16/2001CA2635489A1 Drug delivery apparatus
08/16/2001CA2437289A1 Carrier particles for drug delivery and process for preparation
08/16/2001CA2400323A1 Ocular hypotensive lipids
08/16/2001CA2400186A1 Microencapsulation and sustained release of biologically active agent
08/16/2001CA2399944A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
08/16/2001CA2399821A1 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof
08/16/2001CA2399450A1 Gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters or mixtures thereof
08/16/2001CA2399411A1 Water dispersible formulation of paroxetine
08/16/2001CA2399367A1 Pharmaceutical composition for pulmonary delivery
08/16/2001CA2398954A1 Apparatus for providing a red blood cell carrier
08/16/2001CA2398923A1 A group of anti-cancer compounds with specific structure and their production method
08/16/2001CA2398840A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
08/16/2001CA2398543A1 Multi-purpose drug and heat therapy treatment system
08/16/2001CA2398296A1 Method for loading a red blood cell with an agent
08/16/2001CA2398158A1 Ophthalmic use of alpha adrenergic blocking agents
08/16/2001CA2395648A1 Oxazolidinone thioamides with piperazine amide substituents
08/16/2001CA2366522A1 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications
08/16/2001CA2366458A1 Method and system for producing customized cosmetic and pharmaceutical formulations on demand
08/15/2001CN1308674A Multivalent T cell receptor complexes
08/15/2001CN1308653A A membrane or matrix for controlling the permeation rate of drugs
08/15/2001CN1308548A Adhesive microsphere drug delivery composition
08/15/2001CN1308545A Method of increasing bone toughness and stiffness and reducing fractures
08/15/2001CN1308541A Extracts of zanthoxylum bungeanum, pharmaceuti-cal and cosmetic formulations containing them
08/15/2001CN1308539A Process for producing an iron-dextran compound
08/15/2001CN1308537A Steroid-containing cataplasms and process for producing the same
08/15/2001CN1308530A Use of tricyclic antidepressants for local analgesia
08/15/2001CN1308529A Blister containing transdermal therapeutic system and single form of administration
08/15/2001CN1308528A Plaster which contains steroids, and method for the production and use thereof
08/15/2001CN1308527A Topical plaster with non-steroidal antirheumatic agents with an acid group
08/15/2001CN1308526A Composition containing glycerol trinitrate, method for producing said composition and use of the same
08/15/2001CN1308525A Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels
08/15/2001CN1308524A Dry-copying method for producing flat individually dosed preparations of active agents
08/15/2001CN1308523A Pellets having a core coated with a lipid lowering agent and a polymer
08/15/2001CN1308522A Thixotropic formulations for filling capsules
08/15/2001CN1308521A Novel formulation containing paroxetine
08/15/2001CN1308520A Controlled release oral tablet having a unitary core
08/15/2001CN1308091A Preparation of water soluble or water dispersive polymer containing polyether and its application as medicine ingredient or coating agent and adhesive in packing material
08/15/2001CN1308078A Camptothecin derivative and its preparation
08/15/2001CN1307903A Vaccine wine oil adjuvant
08/15/2001CN1307896A Preparation of pile-eliminating turtle shell capsule
08/15/2001CN1307894A Plaster for treating hyperosteogeny and arthrosis
08/15/2001CN1307893A Capsule and its production process
08/15/2001CN1307877A Plaster for cold
08/15/2001CN1307873A Coated Gongyanping tablet in special shape and its making process
08/15/2001CN1307870A Crystallized pirimiphos-methyl composite and its preparation and usage
08/15/2001CN1307867A Mizoribine tablet with improved color
08/15/2001CN1307866A Production process of polymerized micelle with injected medicine and polymerized micelle composite
08/15/2001CN1307865A Nanometer emulsion containing amphiphilic lipoid and polyglycol ester
08/15/2001CN1069542C Medicine for treating chronic hepatism and its preparing process
08/15/2001CN1069541C Medicine for treatment of cancer
08/15/2001CN1069539C Medicinal composition for curing acne and folliculitis and its preparation method
08/15/2001CN1069535C Clinical medicinal prepns. contg. flavongly coside extracted for persimmon leaves, and process for preparing same
08/15/2001CN1069530C Instant powder for mourishing blood and its prepn. method
08/15/2001CN1069527C Medicine for hyperosteogeny and wind cold syndrome
08/15/2001CN1069526C Medicine for curing hyperosteogeny
08/15/2001CN1069522C Transdermal presentation of nitroglycerin for preventing undesired uterine contraction
08/15/2001CN1069521C Improvement of auxiliary material containing chlorohaxanpyridine acetate
08/15/2001CN1069520C Erigeron berviscopus element soft capsule and production method thereof
08/15/2001CN1069519C Radix aconiti kunsezoffil nail element soft capsule and production method thereof
08/15/2001CN1069518C Oral medicine for reducing cholesterol
08/14/2001US6275728 Thin polymer film drug reservoirs
08/14/2001US6274778 Pulverulent sorbitol and its process of preparation
08/14/2001US6274727 Method for producing shaped and unshaped polyol masses
08/14/2001US6274634 Aqueous suspension for eyes; mixture of fluorometholone and hydroxypropylmethyl cellulose
08/14/2001US6274626 Administering a composition of pheniramine maleate and povidone dropwise into the eye to reduce redness, dryness, and itching
08/14/2001US6274609 4-oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4h-1 -benzopyran or its hydrate and a surfactant
08/14/2001US6274605 Administering an insulin sensitivity enhancer with an angiotensin converting enzyme inhibitor to reduce side effects to a diabetic patient
08/14/2001US6274599 Cisapride extended release
08/14/2001US6274592 Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
08/14/2001US6274555 Composition and method for topical animal medication
08/14/2001US6274553 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method
08/14/2001US6274548 Pectic substance as a growth factor stabilizer
08/14/2001US6274370 A fat substitute from intact yeast cell walls; for use as a coloring agent comprising of yeast beta-glucan in foods, pharmaceuticals and cosmetics
08/14/2001US6274175 Prolonged release of GM-CSF
08/14/2001US6274174 Aggregates of spherical multivalent metal alginate microparticles and methods of making them
08/14/2001US6274173 Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
08/14/2001US6274172 Therapeutic effervescent compositions
08/14/2001US6274171 Antidepressant; Side effect reduction of nausea and vomiting
08/14/2001US6274170 Compounds for cardiovascular treatment comprising multi-vitamin and anti-platelet aggregating agents and methods for making and using the same
08/14/2001US6274169 Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
08/14/2001US6274168 Phenytoin sodium pharmaceutical compositions
08/14/2001US6274167 For pre-vaccination or pre-procedural topical anesthetic patch which after removal delineates where anesthetic is and, therefore, where needle should be inserted
08/14/2001US6274166 Transdermal delivery system